BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Modena BD, Kurian SM, Gaber LW, Waalen J, Su AI, Gelbart T, Mondala TS, Head SR, Papp S, Heilman R, Friedewald JJ, Flechner SM, Marsh CL, Sung RS, Shidban H, Chan L, Abecassis MM, Salomon DR. Gene Expression in Biopsies of Acute Rejection and Interstitial Fibrosis/Tubular Atrophy Reveals Highly Shared Mechanisms That Correlate With Worse Long-Term Outcomes. Am J Transplant 2016;16:1982-98. [PMID: 26990570 DOI: 10.1111/ajt.13728] [Cited by in Crossref: 56] [Cited by in F6Publishing: 51] [Article Influence: 9.3] [Reference Citation Analysis]
Number Citing Articles
1 Vanhove T, Goldschmeding R, Kuypers D. Kidney Fibrosis: Origins and Interventions. Transplantation 2017;101:713-26. [PMID: 27941433 DOI: 10.1097/TP.0000000000001608] [Cited by in Crossref: 44] [Cited by in F6Publishing: 23] [Article Influence: 8.8] [Reference Citation Analysis]
2 Taner T, Park WD, Stegall MD. Unique molecular changes in kidney allografts after simultaneous liver-kidney compared with solitary kidney transplantation. Kidney Int. 2017;91:1193-1202. [PMID: 28233612 DOI: 10.1016/j.kint.2016.12.016] [Cited by in Crossref: 28] [Cited by in F6Publishing: 27] [Article Influence: 5.6] [Reference Citation Analysis]
3 Chong AS. B Cell Recruitment Follows Kidney Injury and Maladaptive Repair. Transplantation 2019;103:1527-9. [PMID: 31348434 DOI: 10.1097/TP.0000000000002723] [Reference Citation Analysis]
4 Ventura CG, Whisenant T, Gelbart T, David DSR, Agena F, Salomon DR, David-Neto E, Kurian SM. Discovery and cross-validation of peripheral blood and renal biopsy gene expression signatures from ethnically diverse kidney transplant populations. Am J Transplant 2019;19:3356-66. [PMID: 31152474 DOI: 10.1111/ajt.15482] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
5 Kurian SM, Whisenant TC, Marsh CL. Systems biology approaches in solid organ transplantation. Curr Opin Organ Transplant 2021;26:37-42. [PMID: 33315768 DOI: 10.1097/MOT.0000000000000837] [Reference Citation Analysis]
6 Kurian SM, Velazquez E, Thompson R, Whisenant T, Rose S, Riley N, Harrison F, Gelbart T, Friedewald JJ, Charette J, Brietigam S, Peysakhovich J, First MR, Abecassis MM, Salomon DR. Orthogonal Comparison of Molecular Signatures of Kidney Transplants With Subclinical and Clinical Acute Rejection: Equivalent Performance Is Agnostic to Both Technology and Platform. Am J Transplant 2017;17:2103-16. [PMID: 28188669 DOI: 10.1111/ajt.14224] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 4.6] [Reference Citation Analysis]
7 Dharnidharka VR, Malone A. Biomarkers to detect rejection after kidney transplantation. Pediatr Nephrol 2018;33:1113-22. [PMID: 28631040 DOI: 10.1007/s00467-017-3712-6] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.4] [Reference Citation Analysis]
8 Moreso F, Sellarès J, Soler MJ, Serón D. Transcriptome Analysis in Renal Transplant Biopsies Not Fulfilling Rejection Criteria. Int J Mol Sci 2020;21:E2245. [PMID: 32213927 DOI: 10.3390/ijms21062245] [Reference Citation Analysis]
9 Song L, Fang F, Liu P, Zeng G, Liu H, Zhao Y, Xie X, Tseng G, Randhawa P, Xiao K. Quantitative Proteomics for Monitoring Renal Transplant Injury. Proteomics Clin Appl 2020;14:e1900036. [PMID: 31999393 DOI: 10.1002/prca.201900036] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
10 Borges TJ, Murakami N, Riella LV. Current status of alloimmunity. Curr Opin Nephrol Hypertens 2016;25:556-62. [PMID: 27584931 DOI: 10.1097/MNH.0000000000000267] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
11 Azad TD, Donato M, Heylen L, Liu AB, Shen-Orr SS, Sweeney TE, Maltzman JS, Naesens M, Khatri P. Inflammatory macrophage-associated 3-gene signature predicts subclinical allograft injury and graft survival. JCI Insight 2018;3:95659. [PMID: 29367465 DOI: 10.1172/jci.insight.95659] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 3.5] [Reference Citation Analysis]
12 Leal R, Tsapepas D, Crew RJ, Dube GK, Ratner L, Batal I. Pathology of Calcineurin and Mammalian Target of Rapamycin Inhibitors in Kidney Transplantation. Kidney Int Rep 2018;3:281-90. [PMID: 30276344 DOI: 10.1016/j.ekir.2017.10.010] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
13 Liu P, Tseng G, Wang Z, Huang Y, Randhawa P. Diagnosis of T-cell-mediated kidney rejection in formalin-fixed, paraffin-embedded tissues using RNA-Seq-based machine learning algorithms. Hum Pathol. 2019;84:283-290. [PMID: 30296518 DOI: 10.1016/j.humpath.2018.09.013] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 2.8] [Reference Citation Analysis]
14 Zhang Z, Menon MC, Zhang W, Stahl E, Loza BL, Rosales IA, Yi Z, Banu K, Garzon F, Sun Z, Wei C, Huang W, Lin Q, Israni A, Keating BJ, Colvin RB, Hao K, Murphy B. Genome-wide non-HLA donor-recipient genetic differences influence renal allograft survival via early allograft fibrosis. Kidney Int 2020;98:758-68. [PMID: 32454123 DOI: 10.1016/j.kint.2020.04.039] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
15 Halloran PF, Venner JM, Madill-thomsen KS, Einecke G, Parkes MD, Hidalgo LG, Famulski KS. Review: The transcripts associated with organ allograft rejection. Am J Transplant 2018;18:785-95. [DOI: 10.1111/ajt.14600] [Cited by in Crossref: 67] [Cited by in F6Publishing: 60] [Article Influence: 13.4] [Reference Citation Analysis]
16 Bräsen JH, Khalifa A, Schmitz J, Dai W, Einecke G, Schwarz A, Hallensleben M, Schmidt BMW, Kreipe HH, Haller H, von Vietinghoff S. Macrophage density in early surveillance biopsies predicts future renal transplant function. Kidney Int 2017;92:479-89. [PMID: 28359537 DOI: 10.1016/j.kint.2017.01.029] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 5.0] [Reference Citation Analysis]
17 Cippà PE, Liu J, Sun B, Kumar S, Naesens M, McMahon AP. A late B lymphocyte action in dysfunctional tissue repair following kidney injury and transplantation. Nat Commun 2019;10:1157. [PMID: 30858375 DOI: 10.1038/s41467-019-09092-2] [Cited by in Crossref: 33] [Cited by in F6Publishing: 31] [Article Influence: 11.0] [Reference Citation Analysis]
18 Marx D, Metzger J, Olagne J, Belczacka I, Faguer S, Colombat M, Husi H, Mullen W, Gwinner W, Caillard S. Proteomics in Kidney Allograft Transplantation—Application of Molecular Pathway Analysis for Kidney Allograft Disease Phenotypic Biomarker Selection. Prot Clin Appl 2019;13:1800091. [DOI: 10.1002/prca.201800091] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
19 Gosset C, Viglietti D, Rabant M, Vérine J, Aubert O, Glotz D, Legendre C, Taupin J, Duong Van-huyen J, Loupy A, Lefaucheur C. Circulating donor-specific anti-HLA antibodies are a major factor in premature and accelerated allograft fibrosis. Kidney International 2017;92:729-42. [DOI: 10.1016/j.kint.2017.03.033] [Cited by in Crossref: 29] [Cited by in F6Publishing: 27] [Article Influence: 5.8] [Reference Citation Analysis]
20 Quaglia M, Merlotti G, Guglielmetti G, Castellano G, Cantaluppi V. Recent Advances on Biomarkers of Early and Late Kidney Graft Dysfunction. Int J Mol Sci 2020;21:E5404. [PMID: 32751357 DOI: 10.3390/ijms21155404] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
21 Nankivell BJ. Reply: i-IFTA is better appreciated by its pathology rather than molecules. Am J Transplant 2018;18:769-70. [PMID: 29322621 DOI: 10.1111/ajt.14662] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
22 Dorr CR, Oetting WS, Jacobson PA, Israni AK. Genetics of acute rejection after kidney transplantation. Transpl Int 2018;31:263-77. [PMID: 29030886 DOI: 10.1111/tri.13084] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 2.6] [Reference Citation Analysis]
23 Granata S, Benedetti C, Gambaro G, Zaza G. Kidney allograft fibrosis: what we learned from latest translational research studies. J Nephrol 2020;33:1201-11. [PMID: 32193834 DOI: 10.1007/s40620-020-00726-z] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
24 Varma VK, Kajdacsy-Balla A, Akkina S, Setty S, Walsh MJ. Predicting Fibrosis Progression in Renal Transplant Recipients Using Laser-Based Infrared Spectroscopic Imaging. Sci Rep 2018;8:686. [PMID: 29330374 DOI: 10.1038/s41598-017-19006-1] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
25 Halloran PF, Famulski KS, Reeve J. Molecular assessment of disease states in kidney transplant biopsy samples. Nat Rev Nephrol 2016;12:534-48. [DOI: 10.1038/nrneph.2016.85] [Cited by in Crossref: 86] [Cited by in F6Publishing: 76] [Article Influence: 14.3] [Reference Citation Analysis]
26 Moss A, Kaplan B. Transplantation: Utilizing the transcriptome to predict allograft fibrosis. Nat Rev Nephrol 2016;12:652-3. [PMID: 27641134 DOI: 10.1038/nrneph.2016.134] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
27 Maluf DG, Mueller TF, Mas VR. Hidden Inflammatory Molecular Signatures in Graft Kidney Biopsies: Silent Markers of Graft Fate? Am J Transplant 2016;16:1947-8. [DOI: 10.1111/ajt.13754] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
28 Van Loon E, Lerut E, Naesens M. The time dependency of renal allograft histology. Transpl Int 2017;30:1081-91. [DOI: 10.1111/tri.13042] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.2] [Reference Citation Analysis]
29 Zhang Z, Tang Y, Zhuang H, Lin E, Xie L, Feng X, Zeng J, Liu Y, Liu J, Yu Y. Identifying 4 Novel lncRNAs as Potential Biomarkers for Acute Rejection and Graft Loss of Renal Allograft. J Immunol Res 2020;2020:2415374. [PMID: 33376751 DOI: 10.1155/2020/2415374] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
30 Nankivell BJ, Shingde M, Keung KL, Fung CL, Borrows RJ, O'Connell PJ, Chapman JR. The causes, significance and consequences of inflammatory fibrosis in kidney transplantation: The Banff i-IFTA lesion. Am J Transplant 2018;18:364-76. [PMID: 29194971 DOI: 10.1111/ajt.14609] [Cited by in Crossref: 56] [Cited by in F6Publishing: 53] [Article Influence: 14.0] [Reference Citation Analysis]
31 Wehmeier C, Amico P, Hirt-Minkowski P, Georgalis A, Höenger G, Menter T, Mihatsch M, Burkhalter F, Steiger J, Dickenmann M, Hopfer H, Schaub S. Acute Rejection Phenotypes in the Current Era of Immunosuppression: A Single-Center Analysis. Transplant Direct 2017;3:e136. [PMID: 28361120 DOI: 10.1097/TXD.0000000000000650] [Cited by in Crossref: 14] [Cited by in F6Publishing: 5] [Article Influence: 2.8] [Reference Citation Analysis]
32 Wu H, Malone AF, Donnelly EL, Kirita Y, Uchimura K, Ramakrishnan SM, Gaut JP, Humphreys BD. Single-Cell Transcriptomics of a Human Kidney Allograft Biopsy Specimen Defines a Diverse Inflammatory Response. J Am Soc Nephrol 2018;29:2069-80. [PMID: 29980650 DOI: 10.1681/ASN.2018020125] [Cited by in Crossref: 132] [Cited by in F6Publishing: 89] [Article Influence: 33.0] [Reference Citation Analysis]
33 Nankivell BJ, P’ng CH, Shingde M, Viswanathan S, Achan A, Renthawa J, Sharma RN, Chapman JR. The Pathophysiology and Impact of Inflammation in Nonscarred Renal Interstitium: The Banff i Lesion. Transplantation 2020;104:835-46. [DOI: 10.1097/tp.0000000000002887] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
34 Menon MC, Murphy B, Heeger PS. Moving Biomarkers toward Clinical Implementation in Kidney Transplantation. J Am Soc Nephrol 2017;28:735-47. [PMID: 28062570 DOI: 10.1681/ASN.2016080858] [Cited by in Crossref: 28] [Cited by in F6Publishing: 18] [Article Influence: 5.6] [Reference Citation Analysis]
35 Lefaucheur C, Gosset C, Rabant M, Viglietti D, Verine J, Aubert O, Louis K, Glotz D, Legendre C, Duong Van Huyen JP, Loupy A. T cell-mediated rejection is a major determinant of inflammation in scarred areas in kidney allografts. Am J Transplant 2018;18:377-90. [PMID: 29086461 DOI: 10.1111/ajt.14565] [Cited by in Crossref: 42] [Cited by in F6Publishing: 37] [Article Influence: 8.4] [Reference Citation Analysis]
36 Jeong HJ. Diagnosis of renal transplant rejection: Banff classification and beyond. Kidney Res Clin Pract 2020;39:17-31. [PMID: 32164120 DOI: 10.23876/j.krcp.20.003] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
37 Modena BD, Milam R, Harrison F, Cheeseman JA, Abecassis MM, Friedewald JJ, Kirk AD, Salomon DR. Changes in Urinary Microbiome Populations Correlate in Kidney Transplants With Interstitial Fibrosis and Tubular Atrophy Documented in Early Surveillance Biopsies. Am J Transplant. 2017;17:712-723. [PMID: 27597148 DOI: 10.1111/ajt.14038] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 2.8] [Reference Citation Analysis]
38 Friedewald JJ, Kurian SM, Heilman RL, Whisenant TC, Poggio ED, Marsh C, Baliga P, Odim J, Brown MM, Ikle DN, Armstrong BD, Charette JI, Brietigam SS, Sustento-Reodica N, Zhao L, Kandpal M, Salomon DR, Abecassis MM; Clinical Trials in Organ Transplantation 08 (CTOT-08). Development and clinical validity of a novel blood-based molecular biomarker for subclinical acute rejection following kidney transplant. Am J Transplant. 2019;19:98-109. [PMID: 29985559 DOI: 10.1111/ajt.15011] [Cited by in Crossref: 50] [Cited by in F6Publishing: 51] [Article Influence: 12.5] [Reference Citation Analysis]
39 Fu Q, Liao M, Feng C, Tang J, Liao R, Wei L, Yang H, Markmann JF, Chen K, Deng S. Profiling of mRNA of interstitial fibrosis and tubular atrophy with subclinical inflammation in recipients after kidney transplantation. Aging (Albany NY) 2019;11:5215-31. [PMID: 31343413 DOI: 10.18632/aging.102115] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
40 Bagnasco SM, Rosenberg AZ. Biomarkers of Chronic Renal Tubulointerstitial Injury. J Histochem Cytochem 2019;67:633-41. [PMID: 31242044 DOI: 10.1369/0022155419861092] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
41 Nakagawa K, Tsuchimoto A, Ueki K, Matsukuma Y, Okabe Y, Masutani K, Unagami K, Kakuta Y, Okumi M, Nakamura M, Nakano T, Tanabe K, Kitazono T; Japan Academic Consortium of Kidney Transplantation Investigators. Significance of revised criteria for chronic active T cell–mediated rejection in the 2017 Banff classification: Surveillance by 1‐year protocol biopsies for kidney transplantation. Am J Transplant 2021;21:174-85. [DOI: 10.1111/ajt.16093] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
42 Chamoun B, Caraben A, Torres IB, Sellares J, Jiménez R, Toapanta N, Cidraque I, Gabaldon A, Perelló M, Gonzalo R, O'Valle F, Moreso F, Serón D. A Rejection Gene Expression Score in Indication and Surveillance Biopsies Is Associated with Graft Outcome. Int J Mol Sci 2020;21:E8237. [PMID: 33153205 DOI: 10.3390/ijms21218237] [Reference Citation Analysis]
43 Sun Y, Qiu Z, Wen F, Yin J, Zhou H, Lu H. Revealing Potential Diagnostic Gene Biomarkers Associated with Immune Infiltration in Patients with Renal Fibrosis Based on Machine Learning Analysis. Journal of Immunology Research 2022;2022:1-20. [DOI: 10.1155/2022/3027200] [Reference Citation Analysis]
44 Kung VL, Sandhu R, Haas M, Huang E. Chronic active T cell–mediated rejection is variably responsive to immunosuppressive therapy. Kidney International 2021;100:391-400. [DOI: 10.1016/j.kint.2021.03.027] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
45 Toulza F, Dominy K, Cook T, Galliford J, Beadle J, McLean A, Roufosse C. Technical considerations when designing a gene expression panel for renal transplant diagnosis. Sci Rep 2020;10:17909. [PMID: 33087822 DOI: 10.1038/s41598-020-74794-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
46 Stapleton CP, Conlon PJ, Phelan PJ. Using omics to explore complications of kidney transplantation. Transpl Int 2018;31:251-62. [PMID: 28892567 DOI: 10.1111/tri.13067] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
47 Levitsky J, Asrani SK, Schiano T, Moss A, Chavin K, Miller C, Guo K, Zhao L, Kandpal M, Bridges N, Brown M, Armstrong B, Kurian S, Demetris AJ, Abecassis M; Clinical Trials in Organ Transplantation - 14 Consortium. Discovery and validation of a novel blood-based molecular biomarker of rejection following liver transplantation. Am J Transplant 2020;20:2173-83. [PMID: 32356368 DOI: 10.1111/ajt.15953] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
48 Batal I, Mohan S, De Serres SA, Vasilescu E, Tsapepas D, Crew RJ, Patel SS, Serban G, Mccune K, Husain SA, Chang J, Herter JM, Bhagat G, Markowitz GS, D’agati VD, Hardy MA, Ratner L, Chandraker A. Analysis of dendritic cells and ischemia-reperfusion changes in postimplantation renal allograft biopsies may serve as predictors of subsequent rejection episodes. Kidney International 2018;93:1227-39. [DOI: 10.1016/j.kint.2017.12.015] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
49 Reischig T, Kacer M, Hruba P, Hermanova H, Hes O, Lysak D, Kormunda S, Bouda M. Less renal allograft fibrosis with valganciclovir prophylaxis for cytomegalovirus compared to high-dose valacyclovir: a parallel group, open-label, randomized controlled trial. BMC Infect Dis 2018;18:573. [PMID: 30442095 DOI: 10.1186/s12879-018-3493-y] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 3.5] [Reference Citation Analysis]
50 Mas VR, Maluf DG. Cellular and molecular profiling of graft injury post renal transplantation. Curr Opin Organ Transplant 2017;22:36-45. [PMID: 27941467 DOI: 10.1097/MOT.0000000000000377] [Reference Citation Analysis]
51 Zhou YH. Set-based differential covariance testing for genomics. Stat (Int Stat Inst) 2019;8:e235. [PMID: 31763041 DOI: 10.1002/sta4.235] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
52 Jethwani P, Rao A, Bow L, Menon MC. Donor–Recipient Non-HLA Variants, Mismatches and Renal Allograft Outcomes: Evolving Paradigms. Front Immunol 2022;13:822353. [DOI: 10.3389/fimmu.2022.822353] [Reference Citation Analysis]
53 Mohammed-Ali Z, Tokar T, Batruch I, Reid S, Tavares-Brum A, Yip P, Cardinal H, Hébert MJ, Li Y, Kim SJ, Jurisica I, John R, Konvalinka A. Urine Angiotensin II Signature Proteins as Markers of Fibrosis in Kidney Transplant Recipients. Transplantation 2019;103:e146-58. [PMID: 30801542 DOI: 10.1097/TP.0000000000002676] [Cited by in Crossref: 3] [Article Influence: 1.0] [Reference Citation Analysis]
54 Hara S. Cell mediated rejection revisited: Past, current, and future directions. Nephrology (Carlton) 2018;23 Suppl 2:45-51. [PMID: 29968416 DOI: 10.1111/nep.13283] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
55 Rohan VS, Chavin KD. Knowing the allograft's destiny. Transl Androl Urol 2017;6:313-4. [PMID: 28540243 DOI: 10.21037/tau.2017.03.27] [Reference Citation Analysis]